In vivo and in vitro characterization of azd9343, a novel GABAB receptor agonist and reflux inhibitor

被引：0
|
作者：
Lehmann, Anders
Elebring, Thomas
Jensen, Jorgen
Mattsson, Jan P.
Nilsson, Karolina A.
Saransaari, Pigo
von Unge, Sverker
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A131 / A132
页数：2
相关论文
共 50 条
  • [31] In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT4 receptor
    Mikami, Tadayoshi
    Komada, Tohru
    Sugimoto, Hiromi
    Suzuki, Keiko
    Ohmi, Takashi
    Kimura, Naoji
    Naganeo, Rie
    Nakata, Eriko
    Nakatani, Keigo
    Toga, Tetsuo
    Eda, Hiroyuki
    Sakakibara, Minoru
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 609 (1-3) : 5 - 12
  • [32] In Vitro and In Vivo Characterization of NOSO-502, a Novel Inhibitor of Bacterial Translation
    Racine, Emilie
    Nordmann, Patrice
    Pantel, Lucile
    Sarciaux, Matthieu
    Serri, Marine
    Houard, Jessica
    Villain-Guillot, Philippe
    Demords, Anthony
    Lundberg, Carina Vingsbo
    Gualtieri, Maxime
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (09)
  • [33] In vitro and in vivo characterization of a novel Jak3 tyrosine kinase inhibitor
    Sills, M.
    Appell, K.
    Bohnstedt, A.
    Kimble, E.
    Kingsbury, C.
    Lin, T.
    Ohlmeyer, M.
    Quadros, E.
    Webb, M.
    INFLAMMATION RESEARCH, 2006, 55 : S118 - S119
  • [34] In Vivo and Ex Vivo Characterization of Vilazodone as a Serotonin Reuptake Inhibitor and 5-HT1A Receptor Partial Agonist
    Kehne, John H.
    Bartoszyk, Gerd D.
    Greiner, Hartmut E.
    Pierz, Kerri A.
    Renda, Matthew J.
    Reed, Carol R.
    Athanasiou, Maria C.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 238S - 238S
  • [35] AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo
    Byung-Hyun Cha
    Minjin Jung
    Angela S. Kim
    Victoria C. Lepak
    Brett A. Colson
    David A. Bull
    Youngwook Won
    Journal of Biological Engineering, 15
  • [36] In vitro and in vivo characterization of TC-1827, a novel brain α4β2 nicotinic receptor agonist with pro-cognitive activity
    Bohme, GA
    Letchworth, SR
    Piot-Grosjean, O
    Gatto, GJ
    Obinu, MC
    Caldwell, WS
    Laville, M
    Brunel, P
    Pellerin, R
    Leconte, JP
    Genevois-Borella, A
    Dubedat, P
    Mazadier, M
    Pradier, L
    Bencherif, M
    Benavides, J
    DRUG DEVELOPMENT RESEARCH, 2004, 62 (01) : 26 - 40
  • [37] SLV318, a novel agonist for the dopamine D2 and D3 receptor:: In vitro and in vivo neurochenical characterization
    Hesselink, MB
    van der Neut, M
    Adolfs, T
    Feenstra, R
    Long, S
    van Scharrenburg, G
    MOVEMENT DISORDERS, 2002, 17 : S65 - S65
  • [38] AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo
    Cha, Byung-Hyun
    Jung, Minjin
    Kim, Angela S.
    Lepak, Victoria C.
    Colson, Brett A.
    Bull, David A.
    Won, Youngwook
    JOURNAL OF BIOLOGICAL ENGINEERING, 2021, 15 (01)
  • [39] The GABAB agonist baclofen reduces duodeno-gastro-esophageal reflux (DGER) and symptoms in patients with reflux disease refractory to proton pump inhibitor therapy
    Koek, G
    Sifrim, D
    Degreef, T
    Janssens, J
    Tack, J
    GASTROENTEROLOGY, 2001, 120 (05) : A34 - A34
  • [40] In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
    Puls, Kristina
    Olive-Marti, Aina-Leonor
    Pach, Szymon
    Pinter, Birgit
    Erli, Filippo
    Wolber, Gerhard
    Spetea, Mariana
    PHARMACEUTICALS, 2022, 15 (06)
12345